May 8, 2026

Abridge: Pharma Data Licensing As Second Business

New Intel: Abridge is building a life sciences product line benchmarked against Flatiron. The ambient scribe may end up being the loss leader for a much higher-margin pharma data licensing business.

Abridge

|

Clinical AI

|

Series D+

May 8, 2026

Bedrock Robotics: Deployment Model Still Senior-Engineer Dependent

New Intel: Bedrock Robotics deployments currently require senior robotics engineers onsite, and the team is betting heavily on digital operating manuals to make customers self-sufficient. If that bet fails, deployment velocity caps revenue regardless of capital, because the specialized field-engineering talent pool is small.

Bedrock Robotics

|

Construction Robotics

|

Series B

May 8, 2026

Moonvalley: Becoming Infrastructure Inside Other People's Tools

New Intel: Moonvalley wants to become the video model layer inside tools like Adobe, fal.ai, ComfyUI, and API workflows. That is infrastructure distribution, not a Runway clone.

Moonvalley

|

Generative Video

|

Series A

May 8, 2026

Bedrock Robotics: Preparing To Acquire Or Raise Up

New Intel: Bedrock Robotics is building out senior finance leadership focused on M&A due diligence and capital allocation, right after closing $270M at $1.75B. The setup is for either tuck-in acquisitions of adjacent autonomy IP or a Series C at a higher mark once operator-less deployments land.

Bedrock Robotics

|

Construction Robotics

|

Series B

May 8, 2026

Runway: Consumer mobile app with AI character calling

New Intel: Runway is building a consumer mobile app with AI character calls, storyboard tools, ad workflows, and in-app purchases. That is a different business from its web platform.

Runway

|

Generative Video

|

Series D+

May 8, 2026

Abridge: Nursing Rollout Doubles Seats Per Hospital

New Intel: Abridge is industrializing the rollout of Abridge for Nursing inside existing hospital customers. Doubling seat count without running a new sales cycle is the kind of expansion motion that drives an IPO narrative.

Abridge

|

Clinical AI

|

Series D+

May 8, 2026

Abridge: Quiet Federal Push Into VA And DoD

New Intel: Abridge is building VistA integration capability and standing up a federal policy function in DC. The VA and DoD ambient scribe contracts are the prize, and almost none of their competitors are positioned to chase them.

Abridge

|

Clinical AI

|

Series D+

May 8, 2026

MeltPlan: Building the Palantir of preconstruction decisions.

New Intel: MeltPlan is trying to own code, cost, schedule, and value decisions in preconstruction. That is a big bundle for Seed, and it only works if the shared data model is real.

MeltPlan

|

Construction AI

|

Seed

May 8, 2026

Bedrock Robotics: Internal Agents Attacking Fleet Ops Cost

New Intel: Bedrock Robotics has a dedicated function building internal AI agents for field triage, data annotation, and engineering Q&A. This is a direct attack on the biggest opex line item for deployed autonomy companies, which is human engineers debugging a growing fleet. If it works, Bedrock's unit economics diverge from competitors.

Bedrock Robotics

|

Construction Robotics

|

Series B

May 8, 2026

Flora: Running the Figma Education Playbook on Purpose

New Intel: Flora is dedicating a senior operator to making the tool core curriculum at art and design schools. This is the Figma playbook against Adobe, and it only works if they lock in tier-one programs before competitors notice.

Flora

|

Creative AI

|

Series A